Abstract Library

#619 Diagnostic Accuracy of F-18-DOPA PET or PET/CT in Neuroendocrine Tumors: A Meta-Analysis

Introduction: A specific feature of NETs is amine precursor uptake and decarboxylation; this is the rationale for using PET with F-18-DOPA, a cathecholamine precursor, in diagnosis of NETs.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Treglia G

Authors: Muoio B, Treglia G, Rufini V,

Keywords: PET, PET/CT, F-18-DOPA, neuroendocrine tumors,

#589 Pancreatic neuroendocrine tumors and Diffusion weighted MRI: a better tool for detection?

Introduction: Pancreatic neuroendocrine tumors (pNETs) are often difficult to detect because of small size. Because surgery is curative in localized pNETs, preoperative localization is necessary.

Conference:

Presenting Author:

Authors: Farchione A, Brizi M, Treglia G, Massara R, Stefanelli A,

Keywords: MRI, DWI, pancreatic-neuroendocrine-tumors, PET.,

#580 Diagnostic Performance of Dual Tracer PET/CT in Staging Neuroendocrine Tumors of the Lung

Introduction: Different positron emission tomography/computed tomography (PET/CT) tracers may be useful in staging lung neuroendocrine tumors (LNETs)

Conference:

Presenting Author:

Authors: Treglia G, Stefanelli A, Cardillo G, Lococo F, Rindi G,

Keywords: Neuroendocrine tumors, lung carcinoids, PET/CT,

#484 Diagnostic Accuracy of Gallium-68 Somatostatin Receptor Positron Emission Tomography in Patients with Thoracic and Gastroenteropancreatic Neuroendocrine Tumors: A Meta-Analysis

Introduction: Gallium-68 somatostatin receptor (SMSR) positron emission tomography (PET) is a valuable diagnostic tool for patients with neuroendocrine tumors (NET). To date, a meta-analysis about the diagnostic accuracy of this functional imaging method is lacking.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Treglia G, Rufini V, Castaldi P, Muoio B, Giordano A,

Keywords: PET, Gallium-68, neuroendocrine tumors,

#351 Comparison of 68Ga-Somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma

Introduction: Early detection of recurrences is a crucial step in the management of patients (pts) with medullary thyroid carcinoma (MTC). Currently, there is growing interest for PET tracers in MTC such as: 18F-FDG (reflecting glucose metabolism), 18F-DOPA (reflecting amine decarboxylation), 68Ga-somatostatin analogues (reflecting somatostatin receptors expression)

Conference:

Presenting Author:

Authors: Treglia G, Castaldi P, Villani M, Filice A, Ambrosini V,

Keywords: PET/CT; medullary thyroid carcinoma; recurrence diagnosis.,